Gold- Buy

Posted on | by Leon Hinde

Gold has been under selling pressure from recent USD strength and yields on the US10YR treasuries moving higher. These factors are now largely priced in and we expect to see firmer gold prices over the coming months.

GDX should see increased buying above the $51.50 support level.

Oceana Gold – Review

Posted on | by Leon Hinde

OceanaGold is under Algo Engine buy conditions.

Newcrest and Gold Road remain our preferred allocations, although Oceana Gold offers among the best long-term production growth opportunities through the Haile, Waihi and Golden Point mines.

The 3QCY20 operational result was weak, compared to market expectations with short-term production below estimates. The soft quarter was largely driven by impacts of exceptional rainfall and Covid-19 staffing related matters at Haile.

Origin Energy 1Q21 Production

Posted on | by Leon Hinde

Nat Gas prices continue to rebound from the historic lows reached mid this year.

Origin share price remains under selling pressure but is likely to soon find buying support.

Origin’s September quarter revenue of A$374m was down 39% from the prior quarter. Lower prices were in part offset by higher production volumes.

CURE ETF

Posted on | by Leon Hinde

After recently taking profit in the CURE ETF, we again add the name back onto our watchlist and identify the range where we expect buying support to rebuild.

Buy $58.50 target.

Separate to the above opportunity, we see upside in the large-cap biotech stocks in the US. In particular, we like Abbvie, Biogen, Gilead, Johnson & Johnson, Merk, and Pfizer.

If you’d like to discuss setting up a US broking account with Investor Signals, please call me on 1300 614 002.